ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

14,918Medicare Part D Prescriptions Filled, Including Refills

Rank: 154 out of 6969

$877K Total Retail Price of All Prescriptions

Rank: 181 out of 6969

498 Patients Receiving at Least One Drug in Part D
70%Patients 65 Years and Older
94% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

N/A

Schedule Three
Controlled Substances

20% of this provider’s 498 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

3% of this provider’s 10,922 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

27% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$59 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

30 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
AMLODIPINE BESYLATE 793 637 1 4
OMEPRAZOLE 496 315 2 6
SIMVASTATIN 447 328 3 1
HYDROCODONE-ACETAMINOPHEN 397 269 S3 4 3
GLIPIZIDE 390 299 5 21
FUROSEMIDE 341 263 6 10
METFORMIN HCL 285 203 7 7
LISINOPRIL 266 186 8 2
LEVOTHYROXINE SODIUM 240 137 9 5
TRAMADOL HCL 226 172 10 27
BENAZEPRIL HCL 217 126 11 18
DIOVAN 198 183 12 26
CLONIDINE HCL 187 164 13 59
METOPROLOL TARTRATE 174 111 14 13
AZITHROMYCIN 173 110 15 42
HYDROCHLOROTHIAZIDE 172 109 16 8
IBUPROFEN 165 108 17 29
ATORVASTATIN CALCIUM 163 141 18 11
NOVOLIN R 161 133 19 161
GABAPENTIN 152 123 20 17
POTASSIUM CHLORIDE 147 117 21 30
ACETAMINOPHEN-CODEINE 138 110 S3 22 73
KLOR-CON 8 136 79 23 104
ALLOPURINOL 131 92 24 35
LOVASTATIN 130 60 25 15
FAMOTIDINE 128 90 26 37
DONEPEZIL HCL 128 127 26 32
MEGESTROL ACETATE 128 100 R 26 129
QUETIAPINE FUMARATE 126 97 29 101
ATENOLOL 124 86 30 9
MELOXICAM 122 112 31 36
CARVEDILOL 121 94 32 25
ZOLPIDEM TARTRATE 116 100 33 16
BACLOFEN 109 86 34 86
MIRTAZAPINE 106 94 35 76
FLUTICASONE PROPIONATE 105 62 36 24
PANTOPRAZOLE SODIUM 103 68 37 31
DIVALPROEX SODIUM 102 37 38 103
CRESTOR 98 70 39 39
WARFARIN SODIUM 96 85 40 20
FLUOCINONIDE 93 63 41 134
LANTUS 93 83 41 50
DIOVAN HCT 91 74 43 57
LOSARTAN POTASSIUM 88 86 44 12
GEMFIBROZIL 87 69 45 85
METOCLOPRAMIDE HCL 86 62 46 136
SYMBICORT 85 55 47 149
RISPERIDONE 84 37 48 88
NAMENDA 84 82 48 51
SULFAMETHOXAZOLE-TRIMETHOPRIM 84 43 48 114
DIGOXIN 84 67 48 71
LACTULOSE 83 68 52 131
BENZTROPINE MESYLATE 80 30 R 53 177
JANUVIA 79 66 54 41
HUMULIN R 78 69 55 223
GLYBURIDE 78 66 R 55 54
HYDRALAZINE HCL 77 61 57 106
POLYETHYLENE GLYCOL 3350 77 56 57 127
ADVAIR DISKUS 74 65 59 45
PRAVASTATIN SODIUM 74 62 59 19
ACTOS 73 53 61 61
CARBIDOPA-LEVODOPA 73 61 61 119
LEVOFLOXACIN 72 63 63 109
HALOPERIDOL 70 42 64 244
CARBAMAZEPINE 69 35 65 204
PHENYTOIN SODIUM EXTENDED 66 54 66 169
AMLODIPINE BESYLATE-BENAZEPRIL 66 53 66 91
SINGULAIR 65 40 68 84
TAMSULOSIN HCL 65 46 68 23
ISOSORBIDE DINITRATE 64 64 70 231
INSULIN SYRINGE 63 42 71 60
MECLIZINE HCL 62 61 72 100
COLCRYS 62 50 72 211
NEXIUM 62 48 72 52
PROAIR HFA 62 35 72 33
CLOPIDOGREL 59 44 76 48
SANTYL 57 55 77 280
PLAVIX 56 40 78 68
CLOTRIMAZOLE 55 35 79 259
SPIRIVA 55 45 79 66
RANITIDINE HCL 53 26 81 46
TRIAMCINOLONE ACETONIDE 52 42 82 55
CLOZAPINE 52 0 82 309
HUMULIN 70-30 51 29 84 294
TRICOR 50 34 85 143
CIPROFLOXACIN HCL 50 39 85 64
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Aug. 30, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.